Published Date: 26 Apr 2023
By using interpretation and translation to present information to communities in their native language, public health outreach initiatives frequently aim to break down communication barriers. However, bilingual people from various cultural backgrounds.
Read Full NewsCapricor Therapeutics anticipates that detailed phase 3 data from the HOPE-3 study will be submitted for presentation at a future scientific meeting and for publication in a peer-reviewed journal.
New data from the open-label extension of Harmony Biosciences’ Phase 3 ARGUS trial show that EPX-100 (clemizole) achieved a median 50% reduction in countable motor seizures in patients with Dravet Syndrome.
Long-term treatment with z-rostudirsen over 24 months showed sustained functional improvements across all end points in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.
Michael Sperling, MD, Baldwin Keyes Professor of Neurology at Vice Chair for Research at the Sidney Kimmel Medical College, spoke about the significance of receiving the Founders Award and the current state of epilepsy.
Thunderstorms Linked to Surge in Asthma ER Visits
Redefining Transplant Possibilities: The Emergence of Kidney Xenotransplants
Febuxostat Lowers Serum Uric Acid More Effectively in Gout Patients With CKD
1.
Testosterone recovery linked to overall survival in high-risk prostate cancer
2.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
3.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
4.
Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.
5.
Kate Middleton and Remission: Oncologists Weigh In
1.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
4.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation